What are the mechanisms by which tirzepatide might impact pregnancy and recurrent pregnancy loss?
Fuente:
Zenodo
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Recurso digital |
| Publicado: |
Zenodo
2025
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1866901184723288064 |
|---|---|
| author | Tripdatabase |
| author_facet | Tripdatabase |
| contents | The current evidence on tirzepatide in pregnancy primarily derives from animal studies, which suggest potential fetal harm, though specific human data is lacking. Use of tirzepatide during pregnancy should consider the risk-benefit balance until more human-specific research is available. |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_17691997 |
| institution | Zenodo |
| language | |
| publishDate | 2025 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | What are the mechanisms by which tirzepatide might impact pregnancy and recurrent pregnancy loss? Tripdatabase mechanisms which tirzepatide impact pregnancy recurrent loss The current evidence on tirzepatide in pregnancy primarily derives from animal studies, which suggest potential fetal harm, though specific human data is lacking. Use of tirzepatide during pregnancy should consider the risk-benefit balance until more human-specific research is available. |
| title | What are the mechanisms by which tirzepatide might impact pregnancy and recurrent pregnancy loss? |
| topic | mechanisms which tirzepatide impact pregnancy recurrent loss |
| url | https://doi.org/10.5281/zenodo.17691997 |